Mateus D Marques1,2, Raquel Weinberg1, Shrey Kapoor1, Mohammad R Ostovaneh1,3, Yoko Kato1, Chia Ying Liu1, Steven Shea4, Robyn L McClelland5, Wendy S Post1, David A Bluemke6, João A C Lima1, Bharath Ambale-Venkatesh1,7. 1. Department of Cardiology, School of Medicine, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD, 21287, USA. 2. Cardiology, Federal University of Santa Maria, 1000 Cidade Universitária Bairro - Camobi, Santa Maria - RS, 97105-900, Brazil. 3. Pennsylvania State Milton S. Hershey Medical Center, 500 University Dr, Hershey, PA 17033, USA. 4. Division of General Medicine, Vagelos College of Physicians & Surgeons, Columbia University, 630 W 168th St, New York, NY 10032, USA. 5. Biostatistics, University of Washington, Bldg. 29, Suite 210 Seattle, WA 98115, USA. 6. Department of Radiology, University of Wisconsin, 3252 Clinical Science Center 600 Highland Ave Madison, WI 53792. 7. Department of Radiology and Radiological Sciences, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD, 21287, USA.
Abstract
AIMS: To evaluate whether myocardial fibrosis predicts cardiovascular events (CVEs) and mortality in the Multi-Ethnic Study of Atherosclerosis. METHODS AND RESULTS: Cardiac magnetic resonance (CMR) T1 mapping with gadolinium administration for assessment of extracellular volume fraction (ECV) was performed in 1326 participants, in whom myocardial scar was assessed by late gadolinium enhancement (LGE). The clinical outcomes were defined as all-cause mortality, atherosclerotic CVEs, and incident heart failure (HF) during an average of 8 years of follow-up after the scan. Participants' mean native T1 time was 971 ms [standard deviation (SD) 45.5], ECV was 27 (SD 2.9), and 117 (8.8%) of them had LGE. At the time of the CMR exam, participant age was 68 years (SD 9) and 48% of them were women. Ideal cut-offs were identified using classification and regression trees accounting for time-to-event outcomes for ECV (30%) and native T1 time (954 ms). Over the follow-up period, 106 participants died, 78 developed CVE, and 23 developed HF. After adjustment for risk factors, ECV >30% was associated with death [hazard ratio (HR): 1.67, P < 0.05], incident CVE (HR: 2.02, P < 0.05), and incident HF (HR: 2.85, P < 0.05). After adjustments, native T1 >954 ms was associated with incident CVE (HR: 2.09, P < 0.05). Myocardial scar by LGE was not predictive of clinical outcomes after adjustments. CONCLUSION: ECV is an independent prognostic marker of incident HF, atherosclerotic CVEs, and all-cause mortality. ECV, with its ability to characterize both diffuse and focal fibrosis processes, better predicted incident events than regional myocardial abnormalities as visualized by LGE imaging in a large multi-ethnic population. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To evaluate whether myocardial fibrosis predicts cardiovascular events (CVEs) and mortality in the Multi-Ethnic Study of Atherosclerosis. METHODS AND RESULTS: Cardiac magnetic resonance (CMR) T1 mapping with gadolinium administration for assessment of extracellular volume fraction (ECV) was performed in 1326 participants, in whom myocardial scar was assessed by late gadolinium enhancement (LGE). The clinical outcomes were defined as all-cause mortality, atherosclerotic CVEs, and incident heart failure (HF) during an average of 8 years of follow-up after the scan. Participants' mean native T1 time was 971 ms [standard deviation (SD) 45.5], ECV was 27 (SD 2.9), and 117 (8.8%) of them had LGE. At the time of the CMR exam, participant age was 68 years (SD 9) and 48% of them were women. Ideal cut-offs were identified using classification and regression trees accounting for time-to-event outcomes for ECV (30%) and native T1 time (954 ms). Over the follow-up period, 106 participants died, 78 developed CVE, and 23 developed HF. After adjustment for risk factors, ECV >30% was associated with death [hazard ratio (HR): 1.67, P < 0.05], incident CVE (HR: 2.02, P < 0.05), and incident HF (HR: 2.85, P < 0.05). After adjustments, native T1 >954 ms was associated with incident CVE (HR: 2.09, P < 0.05). Myocardial scar by LGE was not predictive of clinical outcomes after adjustments. CONCLUSION: ECV is an independent prognostic marker of incident HF, atherosclerotic CVEs, and all-cause mortality. ECV, with its ability to characterize both diffuse and focal fibrosis processes, better predicted incident events than regional myocardial abnormalities as visualized by LGE imaging in a large multi-ethnic population. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: John Eng; Robyn L McClelland; Antoinette S Gomes; W Gregory Hundley; Susan Cheng; Colin O Wu; J Jeffrey Carr; Steven Shea; David A Bluemke; Joao A C Lima Journal: Radiology Date: 2015-10-20 Impact factor: 11.105
Authors: Neville Gai; Evrim B Turkbey; Saman Nazarian; Rob J van der Geest; Chia-Ying Liu; João A C Lima; David A Bluemke Journal: Magn Reson Med Date: 2010-12-16 Impact factor: 4.668
Authors: Evrim B Turkbey; Marcelo S Nacif; Mengye Guo; Robyn L McClelland; Patricia B R P Teixeira; Diane E Bild; R Graham Barr; Steven Shea; Wendy Post; Gregory Burke; Matthew J Budoff; Aaron R Folsom; Chia-Ying Liu; João A Lima; David A Bluemke Journal: JAMA Date: 2015-11-10 Impact factor: 56.272
Authors: Marianna Fontana; Steve K White; Sanjay M Banypersad; Daniel M Sado; Viviana Maestrini; Andrew S Flett; Stefan K Piechnik; Stefan Neubauer; Neil Roberts; James C Moon Journal: J Cardiovasc Magn Reson Date: 2012-12-28 Impact factor: 5.364
Authors: Colin J Yi; Colin O Wu; Michael Tee; Chia-Ying Liu; Gustavo J Volpe; Martin R Prince; Gregory W Hundley; Antoinette S Gomes; Rob J van der Geest; Susan Heckbert; João A Lima; David A Bluemke Journal: J Cardiovasc Magn Reson Date: 2015-02-12 Impact factor: 5.364
Authors: Eric Y Yang; Mohamad G Ghosn; Mohammad A Khan; Nickalaus L Gramze; Gerd Brunner; Faisal Nabi; Vijay Nambi; Sherif F Nagueh; Duc T Nguyen; Edward A Graviss; Erik B Schelbert; Christie M Ballantyne; William A Zoghbi; Dipan J Shah Journal: Circ Cardiovasc Imaging Date: 2019-12-16 Impact factor: 7.792